deshistidyl(1)-prolyl(4)-glutamyl(9)- glucagon

a glucagon receptor antagonist

Also Known As:

glucagon, deshistidyl(1)-prolyl(4)-glutamyl(9)-; 1-desHis-4-Pro-9-Glu-glucagon; desHis(1)Pro(4)Glu(9)-glucagon; glucagon, desHis(1)-Pro(4)-Glu(9)-

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Insulin Resistance 10/01/2014 - "Oral glucose tolerance and insulin sensitivity, as assessed by exogenous insulin administration, were significantly (P<0.01 to P<0.001) improved by both desHis(1)Pro(4)Glu(9)-glucagon and desHis(1)Pro(4)Glu(9)(Lys(30)PAL)-glucagon. "
2.	Body Weight (Weight, Body) 10/01/2014 - "Administration of desHis(1)Pro(4)Glu(9)-glucagon and desHis(1)Pro(4)Glu(9)(Lys(30)PAL)-glucagon had no significant effect on body weight, food intake or circulating glucose concentrations during the treatment period. "